最后，针对血液透析患者丙型肝炎的安全有效的治疗方案。 - Suppr

Suppr

超能文献

Finally, safe and effective treatment options for hepatitis C in hemodialysis patients.

作者信息

Bhamidimarri Kalyan Ram, Martin Paul

机构信息

University of Miami, Miami, FL, USA.

出版信息

J Hepatol. 2016 Jul;65(1):7-10. doi: 10.1016/j.jhep.2016.04.003. Epub 2016 Apr 9.

DOI:10.1016/j.jhep.2016.04.003

PMID:27072190

Abstract

摘要

相似文献

Finally, safe and effective treatment options for hepatitis C in hemodialysis patients.最后，针对血液透析患者丙型肝炎的安全有效的治疗方案。

J Hepatol. 2016 Jul;65(1):7-10. doi: 10.1016/j.jhep.2016.04.003. Epub 2016 Apr 9.

Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.维持性血液透析患者的丙型肝炎病毒感染：诊断和治疗建议

Int J Artif Organs. 2017 Feb 10;39(12):590-595. doi: 10.5301/ijao.5000548. Epub 2017 Feb 1.

[Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].终末期慢性肾功能不全患者的丙型病毒性肝炎。III. 病毒定量

Rev Invest Clin. 2001 Jan-Feb;53(1):21-7.

Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.根据透析治疗类型，终末期肾病患者中丙型肝炎病毒基因型的分布情况。

Dig Dis Sci. 2006 Aug;51(8):1420-5. doi: 10.1007/s10620-005-9025-9. Epub 2006 Jul 26.

Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.巴西南部接受透析的终末期肾病患者丙型肝炎病毒的检测：血液透析患者的患病率、危险因素、基因型及病毒载量动态变化

Virol J. 2015 Feb 3;12:8. doi: 10.1186/s12985-015-0238-z.

Hepatitis C virus in chronic dialysis patients.慢性透析患者中的丙型肝炎病毒

Minerva Urol Nefrol. 2005 Sep;57(3):175-97.

Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.接受血液透析的终末期肾病患者急性丙型肝炎的临床和实验室特征

J Clin Gastroenterol. 2008 Feb;42(2):208-11. doi: 10.1097/MCG.0b013e31802dc57f.

[Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].[采用血清学和分子方法对血液透析患者进行乙型和丙型肝炎病毒感染调查]

Mikrobiyol Bul. 2014 Jan;48(1):143-50.

New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment.第二代直接作用抗病毒药物用于治疗肾功能损害患者丙型肝炎病毒的新证据及新出现的证据

J Pharm Pract. 2017 Jun;30(3):359-365. doi: 10.1177/0897190016632128. Epub 2016 Feb 22.

Kinetics of hepatitis C virus load and hemodialysis: is there any influence of the reuse of dialysis membrane on HCV viremia?丙型肝炎病毒载量与血液透析的动力学：透析膜复用对丙型肝炎病毒血症有影响吗？

Scand J Infect Dis. 2012 Mar;44(3):190-6. doi: 10.3109/00365548.2011.627377. Epub 2011 Nov 8.

引用本文的文献

Treatment of chronic hepatitis C with sofosbuvir in a hemodialysis patient: a case report.索磷布韦治疗血液透析患者慢性丙型肝炎 1 例报告

Pan Afr Med J. 2021 Feb 8;38:137. doi: 10.11604/pamj.2021.38.137.20560. eCollection 2021.

Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C.直接抗病毒药物在维持性血液透析合并慢性丙型肝炎患者中的有效性

Medicine (Baltimore). 2020 Nov 25;99(48):e23384. doi: 10.1097/MD.0000000000023384.

Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease.直接作用抗病毒药物治疗慢性肾脏病患者慢性丙型肝炎的安全性和疗效。

BMC Nephrol. 2020 Jan 16;21(1):21. doi: 10.1186/s12882-020-1687-1.

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus.感染丙型肝炎病毒的血液透析和肾移植患者中与直接作用抗病毒药物相关的耐药性替代的流行情况。

Infect Drug Resist. 2018 Oct 25;11:1993-2000. doi: 10.2147/IDR.S169512. eCollection 2018.

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals.直接作用抗病毒药物时代血液透析慢性肾脏病患者丙型肝炎病毒感染的管理。

Clin Mol Hepatol. 2018 Dec;24(4):351-357. doi: 10.3350/cmh.2017.0063. Epub 2018 Mar 16.

Preliminary experience with sofosbuvir-based treatment regimens for patients dependent on hemodialysis.基于索磷布韦的治疗方案用于依赖血液透析患者的初步经验。

Indian J Gastroenterol. 2018 Jan;37(1):72-73. doi: 10.1007/s12664-018-0833-1.

Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4-5 chronic kidney disease.格卡瑞韦加埃尔巴韦以及其他治疗方案用于4 - 5期慢性肾脏病的丙型肝炎感染患者

Ann Transl Med. 2016 Oct;4(Suppl 1):S13. doi: 10.21037/atm.2016.10.41.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验